LAMP1 and neurodegenerative disease: LAMP1 has been recently studied as a potential candidate marker of lysosomal alteration in neurodegenerative diseases with decreases shown in CSF in PD [8, 16, 26], although it has been previously reported to be unaltered in FTD [7].